Abnormal stock returns of public German pharmaceutical companies during the first wave of COVID-19 pandemic
dc.contributor.advisor | Kantšukov, Mark, juhendaja | |
dc.contributor.advisor | Poltimäe, Helen, juhendaja | |
dc.contributor.author | Rustambekova, Shakhlokhon | |
dc.contributor.other | Tartu Ülikool. Sotsiaalteaduste valdkond | et |
dc.contributor.other | Tartu Ülikool. Majandusteaduskond | et |
dc.date.accessioned | 2023-01-27T14:13:18Z | |
dc.date.available | 2023-01-27T14:13:18Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | http://hdl.handle.net/10062/88661 | |
dc.language.iso | eng | et |
dc.publisher | Tartu Ülikool | et |
dc.rights | openAccess | et |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject.other | bakalaureusetööd | et |
dc.subject.other | bachelor's theses | en |
dc.subject.other | ravimifirmad | et |
dc.subject.other | aktsiaturg | et |
dc.subject.other | aktsiad | et |
dc.subject.other | tootlus | et |
dc.subject.other | koroonakriis | et |
dc.subject.other | finantskäitumine | et |
dc.subject.other | Saksamaa | et |
dc.subject.other | pharmaceutical companies | en |
dc.subject.other | equity market | en |
dc.subject.other | shares | en |
dc.subject.other | performance | en |
dc.subject.other | COVID-19 crisis | en |
dc.subject.other | financial behavior | en |
dc.subject.other | Germany | en |
dc.title | Abnormal stock returns of public German pharmaceutical companies during the first wave of COVID-19 pandemic | et |
dc.type | Thesis | et |